K111066 is an FDA 510(k) clearance for the MIGRA TAB, QUICKSPLINT MIGRAINE. Classified as Mouthguard, Prescription (product code MQC).
Submitted by Migratherapy, LLC (Encinitas, US). The FDA issued a Cleared decision on November 22, 2011 after a review of 218 days - an extended review cycle.
This device falls under the Dental FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.
View all Migratherapy, LLC devices